Navigation Links
GeneWize Announces New Skin Clearing Product and Teen Nutrition at Annual Convention
Date:10/7/2010

ORLANDO, Fla., Oct. 7 /PRNewswire/ -- GeneWize Life Sciences www.genewize.com, a subsidiary of GeneLink BioSciences (OTC Bulletin Board: GNLK) announced before a full house of independent GeneWize Wellness Entrepreneurs a new product category targeting the teen market, adding to their current flagship products of DNA-personalized nutrition and skin care.

The new nutrition and skin-clearing products, aimed at the 11-17 year-old age group, were designed by leading doctors, genetic scientists and dietary researchers.  The new products include:

LifeMap YGLT (You're Gonna Love This!) Anti-Acne Skin Serum

  • The first all natural, organic and 100% safe anti-acne product:  No harsh Benzoil Peroxide or other chemicals as in leading acne treatments.
  • Most effective, all natural "acne-active" ingredients available.  Works on the source of the problem to help skin provide a defense against acne and other teen skin problems.
  • Penetrates deep into pores to help clear acne fast
  • Provides 30 different key skin nutrients, vitamins & minerals

LifeMap YGLT (You're Gonna Love This!) Nutrition for Teens

  • Contains the equivalent nutrients of 4 – 6 servings of fruits and vegetables
  • Vitamins A, B, C, D and K, along with essential minerals including calcium for the critical body-growth years
  • Vitamin and Nutritional Supplement ingredients are validated by independent third-party research

About GeneWize Life Sciences:

GeneWize is the direct selling subsidiary of GeneLink BioSciences, a 16 year-old pioneer in Genetically-Guided Wellness.  The GeneWize mission is to make wellness & beauty possible by making it personal- and in doing so, give families an income opportunity providing financial security and personal growth.  Its products are backed by 16 years of research, multiple patented technologies and are manufactured in the USA from the highest quality, freshest ingredients each month and then shipped directly to the consumer.  For more information, go to www.genewize.com.

About GeneLink BioSciences:

GeneLink is a publicly trades (GNLK.OB) genomics, biotechnology, and wellness company engaged in genetic test development, product development, and manufacturing of personalized vitamin, nutritional supplement, and skin care wellness products.  For additional information, please visit www.genelinkbio.com.


'/>"/>
SOURCE GeneWize Life Sciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Parallel 6 , the leading software as a ... Reach Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine ... team. , Using the CONSULT module, patients and physicians can schedule a face to ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
Breaking Biology Technology:
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):